Login

$MGRX SEC Filings

Filed On Filing
16 Nov 2026 10-Q
13 Nov 2026 8-K: Material Modification to Rights of Security Holders; Amendments to Articles/Bylaws; Change in Fiscal Year +1 more

As described in Item 5.03, which is incorporated by reference into this Item 3.03, Mangoceuticals, Inc. (the “Company”) amended its Series B and Series C preferred stock designations effective November 9, 2026, and established its Series...

12 Nov 2026 1-A
06 Nov 2026 8-K: Submission of Matters to a Vote of Security Holders; Shareholder Director Nominations +1 more

On November 2, 2026, the holder of all 50 issued and outstanding shares of Series B Convertible Preferred Stock (the “Series B Preferred Stock”) of Mangoceuticals, Inc. (the “Company”), acting by written consent in lieu of a meeting, app...

06 Nov 2026 PRE 14A
09 Oct 2026 8-K: Entry into a Material Definitive Agreement

This Securities Purchase Agreement (this “Agreement”) is dated as of October 8, 2026 between Mangoceuticals, Inc., a Texas corporation (the “Company”), and each purchaser identified on the signature pages hereto (each, including its succ...

09 Oct 2026 424B5
06 Oct 2026 Form 4: Cohen Jacob D., Director and 1 other

Gave 500,000 shares as a gift · Acquired 500,000 shares (Gift) · Disposed of 0 Convertible Promissory Note (Other Transaction) · 3 more

06 Oct 2026 Form 4: Johnston Eugene M, CFO

Received 100,000 shares as a grant or award

06 Oct 2026 Form 4: Hamilton Alex P., Director

Received 100,000 shares as a grant or award

06 Oct 2026 SCHEDULE 13D/A
01 Oct 2026 8-K: Entry into a Material Definitive Agreement; Completion of Acquisition or Disposition of Assets +2 more

This Agreement has been executed by the individual or entity whose name is set forth under Section I of “Subscriber Information” below (the “Subscriber”), in connection with the Subscriber’s subscription to purchase ___________ Membershi...

21 Aug 2026 8-K: Termination of a Material Definitive Agreement

Re: Mutual Termination of Business Combination Agreement dated July 29, 2026

13 Aug 2026 10-Q
13 Aug 2026 425
06 Aug 2026 425
04 Aug 2026 425
04 Aug 2026 8-K: Other Events

Mangoceuticals Granted 180-Day Extension by Nasdaq to Regain Compliance with Minimum Bid Price Requirement and Comments on Nuclea Energy Business Combination

30 Jul 2026 425
30 Jul 2026 425

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support